Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013
Terms of Reference
Reasons for referral/principal issues for consideration:
To receive evidence on the need for regulation of pharmaceutical industry conduct with regards to interactions with the medical profession, and the appropriateness of the provisions in the bill that place restrictions on these interactions.
For further information, contact:
Senate Finance and Public Administration Committees
PO Box 6100
Canberra ACT 2600